Recently, AgroPages learned that Syngenta (China) has authorized a domestic e-business platform to sell its four products. The authorization will be valid from April 1, 2020 to December 31, 2020.
Authorized sales cover the following:
Maweishi®: azoxystrobin 250G/L
Cuiying®: metalaxyl-M . fludioxonil 62.5g/L
Jintang®: difenoconazole . fludioxonil 32.5g/L
Zhaosheng®: chlorantraniliprole . thiamethoxam 40%
Since 2014, the Chinese agricultural e-business has experienced rapid development, but the development momentum has not been maintained due to the lack of good collaboration with offline channels in respect of pricing and services.
Since the epidemic outbreak this year, more Chinese farmers have to learn online shopping and live broadcast on mobile phones during the lockdown. Hence, online agricultural material business has become popular among farmers. This happens in accord with the critical period of the spring sowing when a pesticide application is needed, and there is a higher expectation from the agricultural material e-business development in the future.
However, the issue is that recently several domestic pesticide enterprises issued statements prohibiting the illegal sale of their pesticides on the Internet. Companies who issued such statements include well-known enterprises Noposion, Mindleader and Sino-Agri Union among others. The reason is that Internet sales are disrupting the market order and constitute unfair competition, which infringes on the legitimate rights and interests of the official sales channels.
In this regard, some industry experts said that pesticide enterprises should provide more consideration to the use of the internet live broadcast and e-business platform to improve the efficiency of traditional agro-technical promotion to change the traditional sales channels.
What are the thoughts of Syngenta’s authorization of sales of the four products this time? How will the company coordinate its online and offline sales tactics in the future? AgroPages contacted people from Syngenta to ask their view on the question, but have not got respond yet.